Pain Relief in Laparoscopic Surgery
Primary Purpose
Pain, Postoperative, Surgery
Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Altered gas (86% CO2, 10% N2O, 4% O2)
Standardized gas (100% CO2)
Sponsored by
About this trial
This is an interventional health services research trial for Pain, Postoperative focused on measuring post-operative pain, recovery, laparoscopy, nitrous oxide
Eligibility Criteria
Inclusion Criteria:
- Woman ≥ 18 years old
- undergoing laparoscopic surgery for endometriosis, uterine myoma's, hysterectomy or colpopexy.
Exclusion Criteria:
- Women < 18 years old
- Males
- Pregnancy
- Conditions associated with chronic pain, such as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease.
- Conditions causing acute pain e.g. abdominal trauma
Sites / Locations
- Jessa Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Altered gas (86% CO2, 10% N2O, 4% O2)
Standard gas (100% CO2)
Arm Description
Surgery with the use of the altered insufflation gas (86% CO2, 10% N2O, 4% O2)
Surgery with the use of the standardized gas (100% CO2)
Outcomes
Primary Outcome Measures
Assessment of post-operative pain with an 11-point numerical rating score (NRS)
Assessement of pain after laparoscopic surgery with the use of the altered gas compared to standard gas with NRS, where 0 means no pain and 10 means worst imaginable pain
Secondary Outcome Measures
Assessment of post-operative pain (NRS)
Assessement of pain at different time points after surgery with an 11-point numerical rating score NRS, where 0 means no pain and 10 means worst imaginable pain
Nausea
Assessment of nausea at different time points after surgery (yes/no)
Post-operative use of piritramide (Dipidolor®)
Dose of piritramide after laparoscopic surgery in patients treated with altered gas compared to patients treated with the standard gas
Assessment of degree of a possible inflammatory reaction
Assessed via standard medical practice: body temperature will be measured in °C in order to investigate fever
Assessment of degree of a possible inflammatory reaction
Assessed via standard medical practice: potential blood samples measuring C-Reactive Protein (in mg/l) which is a measure for inflammation can be measured if needed throughout the study
Time to resumption of transit
Time to first flatus and time to first stool
Assessment of quality of Recovery (QOR)
Assessment of QOR using the 1-item Global Surgical Recovery (GSR) index which represents a single question about the extent to which patients considered themselves to be recovered from surgery ("if 100% recovery means the participants health is back to the same level as it was before the surgery, what percentage of recovery is the participant at now")
Assessment of quality of Recovery (QOR)
Assessment of QOR using the Functional Recovery Index (FRI) questionnaire which assesses functional QOL on an NRS scale and covers 14 items grouped under three factors (pain and social activity, lower limb activity and general physical activity)
Patient satisfaction
Assessement of patient satisfaction via a seven-point Likert scale, where 1 means extremely unsatisfied and 7 means extremely satisfied
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03867552
Brief Title
Pain Relief in Laparoscopic Surgery
Official Title
Pain Relief in Laparoscopic Surgery - to Relief Pain After Laparoscopic Surgery With the Use of a Altered Gas
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
February 17, 2022 (Actual)
Study Completion Date
February 17, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Jessa Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Pain relief after laparoscopic surgery with the use of an altered gas.
Detailed Description
Pain after laparoscopic surgery remains an important concern in the treatment of endometriosis or other gynaecologic laparoscopic surgery. Several trials have demonstrated that the use of an altered insufflation gas (10 % nitrous oxide + 4% oxygen + 86% carbon dioxide) reduces pain. It also decreases inflammation and adhesion formation as a surplus.
With this mono-center, investigator initiated, double-blinded, randomized controlled superiority trial, the investigators want to demonstrate a reduced postoperative pain and peritoneal inflammatory reaction following peritoneal conditioning with an altered insufflation gas compared to the standard carbon dioxide (100% CO2) insufflation gas. Therefore, women undergoing laparoscopic (gynaecological) surgery with an estimated surgical time of >60 minutes will be asked to participate in this trial. Baseline characteristics will be assessed, including the patients' age, body mass index, medial history, American Society of Anesthesiologist Classification (ASA classification), work status, highest level of education, fear for the surgical procedure (using an 8-item surgical fear questionnaire), pre-operative pain (using a Numerical Rating Scale (NRS) were 0= no pain and 10= worst pain imaginable) both in resting position and in an active position), expected pain (NRS), baseline quality of recovery (QOR) (using the 1-item Global Surgical Recovery (GSR) index (3) and the Functional Recovery Index (FRI) (4)) as well as baseline quality of Life (QOL), using the 5-dimensional European Quality of Life (EQ-5D) questionnaire.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Surgery
Keywords
post-operative pain, recovery, laparoscopy, nitrous oxide
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A total of 4 conditions will be assessed: endometriosis, myoma, hysterectomy and colpopexy. For every group of patients receiving the altered gas, a group of controls which are patients receiving the standardized gas will be assessed to compare the results in a double-blinded fashion
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
74 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Altered gas (86% CO2, 10% N2O, 4% O2)
Arm Type
Experimental
Arm Description
Surgery with the use of the altered insufflation gas (86% CO2, 10% N2O, 4% O2)
Arm Title
Standard gas (100% CO2)
Arm Type
Active Comparator
Arm Description
Surgery with the use of the standardized gas (100% CO2)
Intervention Type
Procedure
Intervention Name(s)
Altered gas (86% CO2, 10% N2O, 4% O2)
Intervention Description
Assessment of pain degree after laparoscopic surgery with the altered gas (86% CO2, 10% N2O, 4% O2)
Intervention Type
Procedure
Intervention Name(s)
Standardized gas (100% CO2)
Intervention Description
Assessement of pain degree after laparoscopic surgery with the standardized gas (100% CO2)
Primary Outcome Measure Information:
Title
Assessment of post-operative pain with an 11-point numerical rating score (NRS)
Description
Assessement of pain after laparoscopic surgery with the use of the altered gas compared to standard gas with NRS, where 0 means no pain and 10 means worst imaginable pain
Time Frame
4 hours after laparoscopic surgery
Secondary Outcome Measure Information:
Title
Assessment of post-operative pain (NRS)
Description
Assessement of pain at different time points after surgery with an 11-point numerical rating score NRS, where 0 means no pain and 10 means worst imaginable pain
Time Frame
8 hours, 24 hours and 7 days after laparoscopic surgery
Title
Nausea
Description
Assessment of nausea at different time points after surgery (yes/no)
Time Frame
4 hours, 8 hours, 24 hours and 7 days after laparoscopic surgery
Title
Post-operative use of piritramide (Dipidolor®)
Description
Dose of piritramide after laparoscopic surgery in patients treated with altered gas compared to patients treated with the standard gas
Time Frame
Up to 24 hours after laparoscopic surgery
Title
Assessment of degree of a possible inflammatory reaction
Description
Assessed via standard medical practice: body temperature will be measured in °C in order to investigate fever
Time Frame
Through study completion, up to 7 days after laparoscopic surgery
Title
Assessment of degree of a possible inflammatory reaction
Description
Assessed via standard medical practice: potential blood samples measuring C-Reactive Protein (in mg/l) which is a measure for inflammation can be measured if needed throughout the study
Time Frame
Through study completion, up to 7 days after laparoscopic surgery
Title
Time to resumption of transit
Description
Time to first flatus and time to first stool
Time Frame
Through study completion, up to 7 days after laparoscopic surgery
Title
Assessment of quality of Recovery (QOR)
Description
Assessment of QOR using the 1-item Global Surgical Recovery (GSR) index which represents a single question about the extent to which patients considered themselves to be recovered from surgery ("if 100% recovery means the participants health is back to the same level as it was before the surgery, what percentage of recovery is the participant at now")
Time Frame
24 hours and 7 days after laparoscopic surgery
Title
Assessment of quality of Recovery (QOR)
Description
Assessment of QOR using the Functional Recovery Index (FRI) questionnaire which assesses functional QOL on an NRS scale and covers 14 items grouped under three factors (pain and social activity, lower limb activity and general physical activity)
Time Frame
24 hours and 7 days after laparoscopic surgery
Title
Patient satisfaction
Description
Assessement of patient satisfaction via a seven-point Likert scale, where 1 means extremely unsatisfied and 7 means extremely satisfied
Time Frame
7 days after laparoscopic surgery
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Participant eligibility is based on self-representation
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Woman ≥ 18 years old
undergoing laparoscopic surgery for endometriosis, uterine myoma's, hysterectomy or colpopexy.
Exclusion Criteria:
Women < 18 years old
Males
Pregnancy
Conditions associated with chronic pain, such as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease.
Conditions causing acute pain e.g. abdominal trauma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Björn Stessel, MD, PhD
Organizational Affiliation
Jessa Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jessa Hospital
City
Hasselt
State/Province
Limburg
ZIP/Postal Code
3500
Country
Belgium
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Pain Relief in Laparoscopic Surgery
We'll reach out to this number within 24 hrs